I am a breastfeeding mother and i want to know if it is safe to use Purine-2,6(1H,3H)-dione, 1,3-dimethyl-? Is Purine-2,6(1H,3H)-dione, 1,3-dimethyl- safe for nursing mother and child? Does Purine-2,6(1H,3H)-dione, 1,3-dimethyl- extracts into breast milk? Does Purine-2,6(1H,3H)-dione, 1,3-dimethyl- has any long term or short term side effects on infants? Can Purine-2,6(1H,3H)-dione, 1,3-dimethyl- influence milk supply or can Purine-2,6(1H,3H)-dione, 1,3-dimethyl- decrease milk supply in lactating mothers?
- DrLact safety Score for Purine-2,6(1H,3H)-dione, 1,3-dimethyl- is 1 out of 8 which is considered Safe as per our analyses.
- A safety Score of 1 indicates that usage of Purine-2,6(1H,3H)-dione, 1,3-dimethyl- is mostly safe during lactation for breastfed baby.
- Our study of different scientific research also indicates that Purine-2,6(1H,3H)-dione, 1,3-dimethyl- does not cause any serious side effects in breastfeeding mothers.
- Most of scientific studies and research papers declaring usage of Purine-2,6(1H,3H)-dione, 1,3-dimethyl- safe in breastfeeding are based on normal dosage and may not hold true for higher dosage.
- Score calculated using the DrLact safety Version 1.2 model, this score ranges from 0 to 8 and measures overall safety of drug in lactation. Scores are primarily calculated using publicly available case studies, research papers, other scientific journals and publically available data.
One case of nausea, vomiting and irritability has been described. However, Purine-2,6(1H,3H)-dione, 1,3-dimethyl- has been used as treatment of apnea on premature babies. It can enhance milk production by stimulating prolactin release.
An expert panel considers use of Purine-2,6(1H,3H)-dione, 1,3-dimethyl- to be acceptable during breastfeeding.[1] Maternal Purine-2,6(1H,3H)-dione, 1,3-dimethyl- use may occasionally cause stimulation and irritability and fretful sleep in infants. Newborn and especially preterm infants are most likely to be affected because of their slow elimination and low serum protein binding of Purine-2,6(1H,3H)-dione, 1,3-dimethyl-. There is no need to avoid Purine-2,6(1H,3H)-dione, 1,3-dimethyl- products; however, keep maternal serum concentrations in the lower part of the therapeutic range and monitor the infant for signs of Purine-2,6(1H,3H)-dione, 1,3-dimethyl- side effects. Infant serum Purine-2,6(1H,3H)-dione, 1,3-dimethyl- concentrations can help to determine if signs of agitation are due to Purine-2,6(1H,3H)-dione, 1,3-dimethyl-. Avoiding breastfeeding for an 2 hours after intravenous or 4 hours after an immediate-release oral Purine-2,6(1H,3H)-dione, 1,3-dimethyl- product can decrease the dose received by the breastfed infant. When Purine-2,6(1H,3H)-dione, 1,3-dimethyl- is given as an oral sustained-release product, timing of nursing with respect to the dose is of little or no benefit.
Irritability and fretful sleeping occurred in a 3-day-old breastfed infant on days of maternal aminophylline intake of 200 mg every 6 hours. These effects ceased with discontinuation and recurred on rechallenge over the next 9 months. These effects were probably caused by Purine-2,6(1H,3H)-dione, 1,3-dimethyl- in breastmilk. Another five infants reported in this paper showed no adverse reactions after maternal Purine-2,6(1H,3H)-dione, 1,3-dimethyl- ingestion.[3] Accumulation of Purine-2,6(1H,3H)-dione, 1,3-dimethyl- in infant serum appears most likely in neonates and premature infants because they eliminate Purine-2,6(1H,3H)-dione, 1,3-dimethyl- slowly.[2][5]
Disclaimer:
Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. We do not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.